Archive for January, 2012
Tuesday, January 24th, 2012
From the wire: Aptar Pharma, which develops and manufactures nasal and pulmonary drug-delivery devices, has announced the opening of a new facility near Mumbai, India.
Located at Rabale, Navi Mumbai, the new site includes an ISO Class 7 cleanroom, which will be used primarily to produce the DF30 metering valve platform for ...
Posted in drug delivery systems | Add Comment »
Tuesday, January 24th, 2012
Billed as a Raman homecoming of sorts, the 23d International Conference on Raman Spectroscopy (ICORS) will be held in Bangalore on 12 to 17 August 2012. The meeting will convene at the Indian Institute of Science, which is the original home of Sir C.V. Raman, where many of Raman’s spectroscopic ...
Posted in Conference | Add Comment »
Friday, January 20th, 2012
Medical device manufacturers are migrating to India as medical pipelines in the west get seriously thin, said Professor Balram Bhargava of the All India Institute of Medical Sciences during a lecture at Judge Business School, Cambridge University. He also predicted that China, Israel and India would join forces in ...
Posted in Business report, medical device OEMs | Add Comment »
Friday, January 6th, 2012
Ireland-based medical technology company Covidien plans to acquire local companies and invest in clinical training facilities as part of its expansion plans in India, reports the Hindu Business Line. The US$11 billion company is also aggressively seeking to hire top-tier talent, Arjun Sarker, Managing Director, Indian Sub-Continent, told Business Line.
Posted in medical device OEMs | Add Comment »
Wednesday, January 4th, 2012
Processes for fabricating 3-D porous biomaterials from regenerated silk fibroin (RSF) have been developed by India's NCL Innovations, part of the National Chemical Laboratory. Notably, NCL scientists have been able to accelerate RSF gelation time to produce a porous structure. The process, which typically takes several days, now can be ...
Posted in Materials, Uncategorized | Add Comment »